Skip to content

Analgesic effect of lidocaine in combination with local infiltration anesthesia in unilateral puncture vertebroplasty: a retrospective observational study

Analgesic effect of lidocaine in combination with local infiltration anesthesia in unilateral puncture vertebroplasty: a retrospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094660
Enrollment
Unknown
Registered
2024-12-25
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporotic vertebral compression fracture

Interventions

group A (local infiltration anaesthesia (4~10 ml of 1% lidocaine basic anaesthesia)):NA
group B (local infiltration anaesthesia + 2 ml of 1% lidocaine as intravertebral analgesia):NA
group C (local infiltration anaesthesia + 4 ml of 1% lidocaine as intravertebral analgesia):NA
group D (local infiltration anaesthesia + 6 ml of 1% lidocaine as intravertebral analgesia):NA
group E (local infiltration anaesthesia + 8 ml of 1% lidocaine as intravertebral analgesia:NA

Sponsors

affiliated hospital of jining medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 88 Years

Inclusion criteria

Inclusion criteria: (1) age >=55 years; (2) bone mineral density examination revealed that the bone mineral density was reduced (T value < -1); (3) preoperative lumbar and back discomfort with limited movement, physical examination clear except for pain at the injured vertebra when tapped, with no obvious neurological symptoms; (4) confirmation based on imaging data that the fracture was a single-level osteoporotic vertebral compression fracture; (5) no use of any relevant analgesic drugs before surgery.

Exclusion criteria

Exclusion criteria: (1) vertebral fractures caused by benign or malignant tumours; (2) cognitive impairment, mental illness or communication disorders; (3) severe cardiopulmonary insufficiency and abnormal coagulation; (4) long-term use of glucocorticoids or nonsteroidal anti-inflammatory drugs; (5) other reasons preventing the patient from meeting the requirements.

Design outcomes

Primary

MeasureTime frame
the visual analogue scale (VAS) score;

Secondary

MeasureTime frame
patient satisfaction with intraoperative analgesia;

Countries

China

Contacts

Public ContactLi Yanming

affiliated hospital of jining medical university

lym20050404@aliyun.com+86 15866067775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026